Drug and asset intelligence for Psilocybin-Assisted with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 0
Stage: Development stage unavailable

Mechanism of action

Psychotherapy

Recent signals(2)

ClinicalJuly 22, 2026

Psilocybin-Assisted Psychotherapy Trial for Advanced Cancer Patients Launched

A new clinical trial is investigating the feasibility and safety of psilocybin-assisted psychotherapy for advanced cancer patients experiencing depression and anxiety.

ClinicalJune 25, 2026

Psilocybin-Assisted Psychotherapy Trial for Cancer Survivors Launched

A clinical trial is underway to evaluate the feasibility and safety of psilocybin-assisted psychotherapy for cancer survivors experiencing depression and/or anxiety.

Upcoming milestones

No catalysts indexed for this entity yet.

Related catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Therapeutic areas

Mental Health →

Oncology →

Psychotherapy →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.